Product
Ipratropium + Levosalbutamol
1 clinical trial
1 indication
Indication
Chronic Obstructive Pulmonary DiseaseClinical trial
Randomized, Parallel Group, Phase III, Non-inferiority Study Comparing Ipratropium / Levosalbutamol Fixed Dose Combination in pMDI Form and Ipratropium and Salbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD)Status: Active (not recruiting), Estimated PCD: 2024-06-01